Physician profile
James Bonar
NPI 1871572123
$844.25
in general payments reported to CMS, 2019-2025
9 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $35.90 · 2021: $22.08 · 2022: $29.76 · 2023: $107 · 2024: $85.59 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $207.24 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Smith+Nephew, INC. | $191.40 | 2020-2025 | Renasys Go V2 Home, Renasys Touch, Pico 7 |
| Organogenesis INC. | $126.51 | 2019-2023 | Puraply |
| Mimedx Group, INC. | $125.13 | 2024-2025 | |
| Urgo Medical North America, LLC | $53.64 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kci USA, INC. | $50.63 | 2019-2020 | |
| Convatec INC. | $39.46 | 2019-2021 | |
| Medline Industries LP | $31.82 | 2019 | |
| Aroa Biosurgery Incorporated | $18.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bonar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.